Koers Marapharm Ventures Inc Canadian Securities Exchange
Aandelen
CA56575M1086
Gezondheidszorgvoorzieningen & -diensten
Omzet 2020 | 2,27 3,12 2,13 | Omzet 2021 | 3,15 4,34 2,95 | Marktkapitalisatie | 10,06 mln. 13,86 mln. 9,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -40 mln. -55,11 mln. -37,5 mln. | Nettowinst (verlies) 2021 | -8 mln. -11,02 mln. -7,5 mln. | EV/omzet 2020 | 13.592.488 x |
Nettoschuld 2020 | 5,3 mln. 7,3 mln. 4,97 mln. | Nettoschuld 2021 | 13,31 mln. 18,33 mln. 12,48 mln. | EV/omzet 2021 | 7.417.546 x |
K/w-verhouding 2020 |
-0,45
x | K/w-verhouding 2021 |
-1,08
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 71,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 18-11-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 08-10-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+86,83% | 283 mln. | |
+51,55% | 268 mln. | |
+69,77% | 195 mln. | |
+89,13% | 130 mln. | |
+117,66% | 121 mln. | |
-14,29% | 121 mln. | |
+23,08% | 87,06 mln. | |
+150,00% | 75,33 mln. | |
-6,02% | 52,1 mln. |